PE20120519A1 - Proceso para preparar (e)-n-(4-(3-tertbutil-5-(2, 4-dioxo-3, 4-dihidropirimidin-1 (2h)-il)-2-metoxiestiril)fenil)metanosulfonamida - Google Patents
Proceso para preparar (e)-n-(4-(3-tertbutil-5-(2, 4-dioxo-3, 4-dihidropirimidin-1 (2h)-il)-2-metoxiestiril)fenil)metanosulfonamidaInfo
- Publication number
- PE20120519A1 PE20120519A1 PE2011001686A PE2011001686A PE20120519A1 PE 20120519 A1 PE20120519 A1 PE 20120519A1 PE 2011001686 A PE2011001686 A PE 2011001686A PE 2011001686 A PE2011001686 A PE 2011001686A PE 20120519 A1 PE20120519 A1 PE 20120519A1
- Authority
- PE
- Peru
- Prior art keywords
- compound
- dioxo
- phenyl
- dihydropyrimidin
- metansulphonamide
- Prior art date
Links
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 5
- -1 TRIETILSILANE Chemical compound 0.000 abstract 4
- 239000002904 solvent Substances 0.000 abstract 2
- MEKOFIRRDATTAG-UHFFFAOYSA-N 2,2,5,8-tetramethyl-3,4-dihydrochromen-6-ol Chemical compound C1CC(C)(C)OC2=C1C(C)=C(O)C=C2C MEKOFIRRDATTAG-UHFFFAOYSA-N 0.000 abstract 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 abstract 1
- 241000711549 Hepacivirus C Species 0.000 abstract 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 abstract 1
- 239000003054 catalyst Substances 0.000 abstract 1
- 229910000077 silane Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
- C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
SE REFIERE A UN PROCESO DE OBTENCION DEL COMPUESTO (E)-N-(4-(3-TERT-BUTIL-5-(2,4-DIOXO-3,4-DIHIDROPIRIMIDIN-1(2H)-IL)-2-METOXIESTIRIL)FENIL)METANSULFONAMIDA DE FORMULA (I) QUE COMPRENDE: A) REDUCIR EL COMPUESTO N-(4-((3-TERT-BUTIL-5-(2,4-DIOXO-3,4-DIHIDROPIRIMIDIN-1(2H)-IL)-2-METOXIFENIL)ETINIL)FENIL)METANSULFONAMIDA DE FORMULA (6) EMPLEANDO UN SILANO TAL COMO TRIETILSILANO, FENILSILANO, HEXAMETILDISILANO, ENTRE OTROS, Y EN PRESENCIA DE UN CATALIZADOR DE PALADIO Y UN SOLVENTE TAL COMO DIMETILFORMAMIDA, DIMETILACETAMIDA, ENTRE OTROS. DONDE EL COMPUESTO (6) SE OBTIENE HACIENDO REACCIONAR EL COMPUESTO 1-(3-TERT-BUTIL-5-ETINIL-4-METOXIFENIL)PIRIMIDIN-2,4(1H,3H)-DIONA CON UNO DE LOS COMPUESTOS SELECCIONADOS DE N-(4-YODOFENIL)METANSULFONAMIDA, N-(4-BROMOFENIL)METANSULFONAMIDA, N-(4-CLOROFENIL)METANSULFONAMIDA, ENTRE OTROS, EN PRESENCIA DE UNA BASE Y UN SOLVENTE. DICHO COMPUESTO DE FORMULA (I) ES UTIL PARA INHIBIR EL VIRUS DE LA HEPATITIS C
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16270509P | 2009-03-24 | 2009-03-24 | |
| US31671310P | 2010-03-23 | 2010-03-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20120519A1 true PE20120519A1 (es) | 2012-06-03 |
Family
ID=42136100
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2011001686A PE20120519A1 (es) | 2009-03-24 | 2010-03-24 | Proceso para preparar (e)-n-(4-(3-tertbutil-5-(2, 4-dioxo-3, 4-dihidropirimidin-1 (2h)-il)-2-metoxiestiril)fenil)metanosulfonamida |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP2411372B1 (es) |
| JP (1) | JP5744003B2 (es) |
| KR (1) | KR101665955B1 (es) |
| CN (1) | CN102361858B (es) |
| AU (1) | AU2010229975B2 (es) |
| BR (1) | BRPI1009854A2 (es) |
| CA (1) | CA2753825C (es) |
| CL (1) | CL2011002278A1 (es) |
| CO (1) | CO6450678A2 (es) |
| CR (1) | CR20110524A (es) |
| DO (1) | DOP2011000297A (es) |
| EC (1) | ECSP11011415A (es) |
| ES (1) | ES2488821T3 (es) |
| GT (1) | GT201100241A (es) |
| IL (1) | IL214858A (es) |
| MX (1) | MX2011010049A (es) |
| MY (1) | MY169288A (es) |
| NZ (1) | NZ594923A (es) |
| PE (1) | PE20120519A1 (es) |
| RU (1) | RU2524573C2 (es) |
| SG (1) | SG174211A1 (es) |
| WO (1) | WO2010111348A1 (es) |
| ZA (1) | ZA201106511B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9255074B2 (en) | 2010-07-16 | 2016-02-09 | Abbvie Inc. | Process for preparing antiviral compounds |
| BR112013001138A2 (pt) | 2010-07-16 | 2016-07-05 | Abbvie Inc | ligantes de fosfina para reações catalíticas |
| US8975443B2 (en) | 2010-07-16 | 2015-03-10 | Abbvie Inc. | Phosphine ligands for catalytic reactions |
| AU2011278927B2 (en) | 2010-07-16 | 2015-05-21 | Abbvie Ireland Unlimited Company | Process for preparing antiviral compounds |
| TWI558400B (zh) * | 2011-03-18 | 2016-11-21 | 艾伯維有限公司 | 苯基尿嘧啶化合物之調配物 |
| US20160375017A1 (en) | 2015-06-26 | 2016-12-29 | Abbvie Inc. | Solid Pharmaceutical Compositions for Treating HCV |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001021624A1 (en) * | 1999-09-20 | 2001-03-29 | Fuji Photo Film Co., Ltd. | Compounds for fluorescence labeling |
| AU779412B2 (en) * | 1999-09-22 | 2005-01-20 | Sanofi-Aventis Deutschland Gmbh | 4-benzylaminoquinoline conjugates with bile acid and their heteroanalogues, methods for producing the same, medicaments containing these compounds and their use |
| DE10051981A1 (de) * | 2000-10-20 | 2002-05-02 | Bayer Ag | Substituierte Phenyluracile |
| EP2038253A1 (en) * | 2006-05-30 | 2009-03-25 | Arrow Therapeutics Limited | Biphenyl derivatives and their use in treating hepatitis c |
| MX2010002904A (es) * | 2007-09-17 | 2010-06-02 | Abbott Lab | N-fenil-dioxo-hidropirimidinas utiles como inhibidores de virus de hepatitis c (hcv). |
| RU2543620C2 (ru) * | 2007-09-17 | 2015-03-10 | Эббви Бахамаз Лтд. | Производные урацила или тимина для лечения гепатита с |
| ES2383273T3 (es) * | 2008-07-23 | 2012-06-19 | F. Hoffmann-La Roche Ag | Compuestos heterocíclicos antivíricos |
-
2010
- 2010-03-24 JP JP2012502196A patent/JP5744003B2/ja active Active
- 2010-03-24 WO PCT/US2010/028433 patent/WO2010111348A1/en not_active Ceased
- 2010-03-24 CN CN201080013374.7A patent/CN102361858B/zh active Active
- 2010-03-24 RU RU2011142757/04A patent/RU2524573C2/ru active
- 2010-03-24 AU AU2010229975A patent/AU2010229975B2/en active Active
- 2010-03-24 CA CA2753825A patent/CA2753825C/en active Active
- 2010-03-24 EP EP10711968.7A patent/EP2411372B1/en active Active
- 2010-03-24 PE PE2011001686A patent/PE20120519A1/es active IP Right Grant
- 2010-03-24 MY MYPI2011004471A patent/MY169288A/en unknown
- 2010-03-24 BR BRPI1009854-2A patent/BRPI1009854A2/pt not_active Application Discontinuation
- 2010-03-24 KR KR1020117024825A patent/KR101665955B1/ko active Active
- 2010-03-24 MX MX2011010049A patent/MX2011010049A/es active IP Right Grant
- 2010-03-24 ES ES10711968.7T patent/ES2488821T3/es active Active
- 2010-03-24 NZ NZ594923A patent/NZ594923A/xx unknown
- 2010-03-24 SG SG2011063179A patent/SG174211A1/en unknown
-
2011
- 2011-08-24 EC EC2011011415A patent/ECSP11011415A/es unknown
- 2011-08-28 IL IL214858A patent/IL214858A/en active IP Right Grant
- 2011-09-06 ZA ZA2011/06511A patent/ZA201106511B/en unknown
- 2011-09-14 CL CL2011002278A patent/CL2011002278A1/es unknown
- 2011-09-20 GT GT201100241A patent/GT201100241A/es unknown
- 2011-09-21 CO CO11123197A patent/CO6450678A2/es active IP Right Grant
- 2011-09-23 DO DO2011000297A patent/DOP2011000297A/es unknown
- 2011-10-04 CR CR20110524A patent/CR20110524A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ594923A (en) | 2013-11-29 |
| RU2011142757A (ru) | 2013-04-27 |
| CL2011002278A1 (es) | 2012-03-09 |
| KR20110137372A (ko) | 2011-12-22 |
| IL214858A (en) | 2015-05-31 |
| CN102361858A (zh) | 2012-02-22 |
| EP2411372A1 (en) | 2012-02-01 |
| MX2011010049A (es) | 2011-10-11 |
| CN102361858B (zh) | 2014-07-23 |
| ECSP11011415A (es) | 2011-11-30 |
| CR20110524A (es) | 2012-01-19 |
| HK1166798A1 (en) | 2012-11-09 |
| EP2411372B1 (en) | 2014-07-23 |
| AU2010229975A1 (en) | 2011-09-29 |
| CA2753825C (en) | 2017-10-17 |
| GT201100241A (es) | 2015-08-19 |
| DOP2011000297A (es) | 2011-10-15 |
| AU2010229975B2 (en) | 2015-05-21 |
| IL214858A0 (en) | 2011-11-30 |
| SG174211A1 (en) | 2011-10-28 |
| CA2753825A1 (en) | 2010-09-30 |
| BRPI1009854A2 (pt) | 2015-08-25 |
| MY169288A (en) | 2019-03-21 |
| RU2524573C2 (ru) | 2014-07-27 |
| KR101665955B1 (ko) | 2016-10-13 |
| WO2010111348A1 (en) | 2010-09-30 |
| JP5744003B2 (ja) | 2015-07-01 |
| JP2012521990A (ja) | 2012-09-20 |
| ES2488821T3 (es) | 2014-08-29 |
| ZA201106511B (en) | 2012-05-30 |
| CO6450678A2 (es) | 2012-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20091842A1 (es) | Pirrolidinonas como activadores de glucoquinasa | |
| PE20120519A1 (es) | Proceso para preparar (e)-n-(4-(3-tertbutil-5-(2, 4-dioxo-3, 4-dihidropirimidin-1 (2h)-il)-2-metoxiestiril)fenil)metanosulfonamida | |
| PE20211700A1 (es) | Compuesto heterociclico y su uso | |
| PE20090992A1 (es) | Derivados de fenil-amino-pirimidina como agentes inhibidores de cinasa | |
| PE20120937A1 (es) | Compuestos derivados de quinolina y quinoxalina como agentes antivirales | |
| PE20131165A1 (es) | Analogos de carba-nucleosidos sustituidos con 2'-fluoro para tratamiento antiviral | |
| CO6241076A2 (es) | Compuestos de benzamida y aplicaciones de los mismos | |
| SV2009003157A (es) | Profarmaco de compuesto de cinamida | |
| NZ596538A (en) | Haloalkyl heteroaryl benzamide compounds | |
| PE20141041A1 (es) | Compuestos, metodos y formulaciones parasiticidas | |
| UY33226A (es) | Compuestos de pirrolopirimidina deuterada como inhibidores de la cdk4/6 | |
| AR065649A1 (es) | Dionas ciclicas herbicidamente activas, procesos de obtencion y composiciones. | |
| PE20090326A1 (es) | Compuestos heterociclos como inhibidores de erk | |
| CL2011002706A1 (es) | Compuestos derivados de 4-(1,3-oxazol-2-il)-1h-indazol; composicion farmaceutica que los comprende; y sus usos en el tratamiento de enfermedades tales como epoc, autoinmunes, asma, entre otras. | |
| DE602005023343D1 (de) | Pyrimidinderivate als gpcr-agonisten | |
| PE20140923A1 (es) | Preparacion solida que comprende alogliptina y clorhidrato de metformina | |
| AR072952A1 (es) | Compuestos de 2-imino-3-metilpirrolopirimidinona fenilo-sustituida como inhibidores de bace-1, composiciones y su uso | |
| EA200900676A1 (ru) | Ингибиторы вируса гепатита с | |
| PE20141996A1 (es) | Compuestos con actividad nematicida | |
| RU2015103515A (ru) | Производное соединение сложного эфира 2-аминоникотиновой кислоты и бактерицид, содержащий то же самое в качестве активного ингредиента | |
| MA38540A1 (fr) | Dérivés de naphtyridine utiles comme antagonistes de l'intégrine alpha-v-bêta-6 | |
| CL2011000242A1 (es) | Uso de compuestos derivados de fenilaminopirimidina para tratar talasemia alfa, delta y anemia celular falciforme, talasemia mayor, talasemia menor, talasemia e-beta o talasemia beta falciforme, o para mejorar o retrasar los sintomas de las mismas y uso de un compuesto especifico para tratar la talasemia. | |
| BRPI0615705A2 (pt) | processo para preparar um composto, e, composto | |
| PE20140934A1 (es) | Derivados de pirazol | |
| PE20100487A1 (es) | Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |